Bovine Gelatin Market

Bovine Gelatin Market Analysis and Forecast by Fact.MR

The bovine gelatin market, valued at USD 3.7 billion in 2025, is expanding at a 4.2% CAGR to reach USD 5.818 billion by 2036. Bovine gelatin is a protein derived from the hydrolysis of collagen in bovine hides, bones, tendons, and ligaments, delivering gelling, stabilising, emulsifying, and film-forming properties across food, pharmaceutical, nutraceutical, cosmetic, and industrial applications. Growth is shaped by pharmaceutical capsule production expansion, confectionery gelling agent demand, collagen supplement market growth, and food texturising ingredient requirements.

Summary of Bovine Gelatin Market

• Market Snapshot
  • The bovine gelatin market is valued at USD 3.7 billion in 2025.
  • Estimated market value for 2026 is USD 3.855 billion, projected to reach USD 5.818 billion by 2036.
  • A CAGR of 4.2% is forecast for the 2026 to 2036 assessment period.
  • Incremental opportunity of USD 1.963 billion between 2026 and 2036.
  • Food-grade gelatin holds 36.8% of the product segment, with bovine hide at 52.6% of source demand.
  • India and China are the fastest-growing markets for bovine gelatin consumption.
• Demand and Growth Drivers
  • Global pharmaceutical hard and soft capsule production exceeds 500 billion units annually, with bovine gelatin serving as the primary capsule shell material due to its excellent film-forming properties, dissolution characteristics, and regulatory acceptance across all pharmaceutical markets.
  • Confectionery industry demand for gelling agents in gummy sweets, marshmallows, and jelly products sustains food-grade gelatin consumption, with gummy supplement and gummy vitamin formats creating additional demand at the food-pharmaceutical intersection.
  • Collagen peptide supplement market growth at 8 to 10% annually is driving demand for bovine gelatin hydrolysates marketed as beauty-from-within, joint health, and skin elasticity supplements.
  • Industrial gelatin applications in photography, microencapsulation, and adhesive production maintain a stable demand base alongside food and pharmaceutical consumption.
• Product and Segment View
  • Food-grade gelatin holds 36.8% of the product segment, reflecting the established position of gelatin in confectionery, dairy, and bakery applications.
  • Food and beverages capture 41.5% of application demand, driven by gelling, stabilising, and texturising requirements in food manufacturing.
  • Powder gelatin accounts for 44.2% of form demand, reflecting the versatility and ease of use of powdered gelatin in manufacturing processes.
  • Key segmentation includes:
    • Product: Food Grade Gelatin, Pharmaceutical Grade Gelatin, Industrial Grade Gelatin, Specialty Gelatin, Edible Gelatin Derivatives
    • Application: Food and Beverages, Pharmaceuticals, Nutraceuticals, Cosmetics and Personal Care, Industrial Applications
    • Source: Bovine Hide, Bovine Bones, Bovine Tendons and Ligaments
    • Form: Powder Gelatin, Sheet Gelatin, Liquid Gelatin
    • Bloom Strength: Medium Bloom, Low Bloom, High Bloom, Ultra High Bloom
• Geography and Competitive Outlook
  • North America accounts for significant revenue, with the USA generating USD 1.38 billion in 2025.
  • East Asia is expanding, with Japan contributing USD 0.196 billion and South Korea contributing USD 0.114 billion.
  • Gelita holds approximately 12.0% of global market share through its position as the world's largest gelatin and collagen peptide manufacturer.
  • Rousselot (Darling Ingredients), PB Leiner, and Nitta Gelatin compete on production scale, source diversification, and pharmaceutical-grade capabilities.
• Analyst Opinion
  • The bovine gelatin market faces a dual dynamic: sustained demand from pharmaceutical capsule and confectionery applications, and competition from plant-based and marine alternatives in consumer-facing products. The commercial opportunity lies in two strategies: maintaining pharmaceutical-grade quality leadership where bovine gelatin's functional properties remain unmatched by alternatives, and developing collagen peptide value-added products that capture the growing beauty and health supplement market at premium price points.

Key Growth Drivers, Constraints, and Opportunities

Key Factors Driving Growth

• Pharmaceutical capsule demand is the single largest application driver for bovine gelatin. Global soft gel capsule production alone exceeds 100 billion units annually, per Capsugel/Lonza industry references, with bovine gelatin providing the film-forming, dissolution, and oxygen barrier properties that capsule production requires. Bovine gelatin's regulatory acceptance (Ph. Eur., USP, JP pharmacopoeia compliance) across all major pharmaceutical markets provides a compliance advantage over alternative materials.
• Gummy supplement and gummy vitamin formats are the fastest-growing delivery system in the nutraceutical market, growing at 12 to 15% annually per CRN data. Bovine gelatin's gelling properties at specific bloom strengths produce the chewy texture that consumers expect in gummy products, and bovine gelatin gummies are preferred over porcine alternatives in markets with halal dietary requirements.
• Collagen peptide supplements derived from bovine gelatin hydrolysis are growing at 8 to 10% annually, driven by consumer demand for beauty-from-within products targeting skin elasticity, hair strength, and joint health. Bovine collagen peptides command retail prices of USD 30 to USD 80 per kilogram, delivering significant value-added processing margin above raw gelatin.

Key Market Constraints

• BSE (bovine spongiform encephalopathy) risk perception continues to affect bovine gelatin acceptance in certain markets. While scientific evidence confirms that gelatin production processes (acid/alkaline treatment, heat processing) inactivate BSE prions, consumer and regulatory sensitivity persists, particularly in Japan and certain European markets.
• Halal and kosher certification requirements create sourcing complexity. Bovine gelatin must be sourced from animals slaughtered according to halal or kosher requirements, and certification documentation must trace the gelatin from slaughterhouse to finished product. This certification process adds cost and limits supplier options.
• Competition from plant-based alternatives (agar, carrageenan, pectin, modified starch) and porcine gelatin constrains bovine gelatin market share in price-sensitive food applications where gelling functionality rather than specific gelatin properties is the primary requirement.

Key Opportunity Areas

• Pharmaceutical-grade bovine gelatin for specialised drug delivery systems (enteric-coated capsules, modified-release capsules, liquid-filled capsules) is a high-value growth niche. Specialised pharmaceutical gelatin commands prices of USD 15 to USD 40 per kilogram versus USD 4 to USD 8 for standard food-grade gelatin.
• Halal-certified bovine gelatin is growing at 10 to 12% annually as Muslim-majority markets expand pharmaceutical and food manufacturing. The global halal gelatin market is supply-constrained, as halal bovine gelatin production requires dedicated slaughterhouse sourcing and certified processing infrastructure.
• Bioactive collagen peptide development for targeted health applications (Type I for skin, Type II for joints, Type III for cardiovascular) is creating differentiated product positioning that commands premiums above generic collagen supplements.

Segment-wise Analysis of the Bovine Gelatin Market

• Food-grade gelatin holds 36.8% of the product segment, reflecting established food manufacturing demand.
• Food and beverages capture 41.5% of application demand, driven by confectionery and dairy gelling requirements.
• Medium bloom accounts for 38.7% of bloom strength demand, reflecting the broadest range of food and pharmaceutical applications.

Which product type dominates the Bovine Gelatin Market?

Food-grade gelatin controls 36.8% of the product segment. Food-grade bovine gelatin serves confectionery (gummy bears, marshmallows, jelly), dairy (yogurt, mousse, panna cotta), bakery (glazes, fillings), and beverage (clarification, stabilisation) applications. Food-grade gelatin specifications define bloom strength (100 to 300 bloom), mesh size, clarity, and microbiological limits.

Pharmaceutical-grade gelatin holds the second-largest share, serving hard capsule and soft gel capsule production with stringent pharmacopoeia compliance requirements. Specialty gelatin serves niche applications including microencapsulation, photographic film, and biomedical research.

Which application drives demand in the Bovine Gelatin Market?

Food and beverages account for 41.5% of application demand. Confectionery is the largest food sub-application, with gummy sweets consuming over 30% of global food-grade gelatin production. Dairy applications (yogurt texturising, dessert gelling) and beverage applications (juice clarification, wine fining) contribute additional food-grade demand.

Pharmaceuticals hold the second-largest share, driven by capsule shell production. Nutraceuticals are the fastest-growing application, driven by collagen peptide supplements and gummy vitamin manufacturing.

Which source captures the largest share in the Bovine Gelatin Market?

Bovine hide accounts for 52.6% of source demand. Type B gelatin (alkaline-processed) from bovine hides is the dominant product, delivering high bloom strength, excellent clarity, and consistent gelling properties. Bovine hides from South American, Indian, and Australian cattle are the primary raw material sources for the global gelatin industry.

Bovine bones hold the second-largest source share, producing Type A gelatin (acid-processed) with different functional characteristics. Bovine tendons and ligaments serve niche applications requiring specific collagen type profiles.

Which Product Trend is Shaping the Next Phase of Growth in the Bovine Gelatin Market?

The fastest-growing product trend in the bovine gelatin market is the development of type-specific collagen peptide products with targeted health benefit positioning. Traditional bovine gelatin is sold as a generic protein ingredient defined by bloom strength and grade. The emerging trend segments bovine collagen into Type I (skin, bones, tendons), Type II (cartilage, joints), and Type III (blood vessels, organs) peptide products, each marketed for specific health applications with supporting clinical evidence.

The commercial significance is that type-specific collagen peptides command retail prices 2 to 5 times above generic bovine gelatin. Type II collagen peptides for joint health (UC-II, Peptan) are marketed with published clinical trial data demonstrating cartilage protection and joint mobility benefits. Type I collagen peptides for skin health carry clinical data on skin elasticity and hydration improvement. Companies that invest in collagen type fractionation technology and clinical evidence programmes are capturing the premium supplement segment.

Regional Outlook Across Key Markets

• North America is a major market, with the USA contributing USD 1.38 billion in 2025.
• East Asia is expanding, with Japan at USD 0.196 billion and South Korea at USD 0.114 billion.
• South Asia and Pacific is the fastest-growing region, driven by India's pharmaceutical and food manufacturing growth.
• Europe is a mature market with established pharmaceutical and confectionery gelatin demand.

CAGR Table

Source: Fact.MR analysis, based on proprietary forecasting model and primary research.

India: pharmaceutical manufacturing and halal gelatin demand drive growth

India leads country-level growth. India's pharmaceutical manufacturing sector, the world's largest by volume of generic drug production, is creating sustained demand for pharmaceutical-grade bovine gelatin capsule shells. India is also a major bovine hide source, with domestic gelatin production expanding alongside pharmaceutical sector growth.

• India's pharmaceutical capsule production exceeded 50 billion units in 2024, per Indian Drug Manufacturers Association data, with bovine gelatin as the primary capsule material.

China: confectionery growth and pharmaceutical demand drive adoption

China records the second-highest growth rate. Chinese gelatin demand is driven by confectionery industry expansion (gummy vitamins, jelly products), pharmaceutical capsule production growth, and the expanding collagen supplement market targeting Chinese consumers.

• China's gelatin consumption exceeded 80,000 tonnes in 2024, per China Gelatin Industry Association data.

Mexico: confectionery production and pharmaceutical manufacturing sustain demand

Mexico's growth reflects confectionery production for domestic and export markets and expanding pharmaceutical manufacturing. Mexican confectionery manufacturers use bovine gelatin in gummy and jelly product lines distributed throughout Latin America.

• Mexico's confectionery market grew 5% in 2024, per CANAINCA data, with gummy products as the fastest-growing confectionery sub-category.

USA: pharmaceutical capsule production and collagen supplement demand sustain the market

The USA generates USD 1.38 billion in 2025. US demand is driven by pharmaceutical capsule production, confectionery manufacturing, and the rapidly growing collagen supplement market. The US collagen supplement market exceeded USD 2 billion in 2024, with bovine collagen peptides as the leading source type.

• US collagen supplement sales grew 12% in 2024, per NBJ data, with bovine-sourced collagen maintaining the largest share of supplement collagen sales.

Germany: pharmaceutical quality standards and confectionery heritage define the market

Germany's growth reflects pharmaceutical-grade gelatin demand and the country's confectionery manufacturing heritage. Gelita (headquartered in Eberbach) and other German gelatin producers maintain pharmaceutical-grade production standards that serve the European pharmaceutical industry.

• Germany's gelatin production exceeded 30,000 tonnes in 2024, per VDG data, maintaining its position as Europe's largest gelatin producing country.

South Korea: K-beauty collagen demand and pharmaceutical growth drive adoption

South Korea's growth is driven by the K-beauty industry's collagen supplement and cosmetic ingredient demand and pharmaceutical capsule production. Korean consumers are among the world's highest per-capita collagen supplement consumers.

• South Korea's collagen supplement market grew 10% in 2024, per KFDA data, with bovine collagen maintaining a significant share alongside marine collagen.

Japan: pharmaceutical precision and beauty supplement culture sustain demand

Japan contributes USD 0.196 billion in 2025. Japanese gelatin demand reflects the country's pharmaceutical manufacturing precision requirements and the established beauty supplement culture. Nitta Gelatin (headquartered in Osaka) is a major domestic and export gelatin producer.

• Japan's beauty supplement market exceeded JPY 250 billion in 2024, per JFMA data, with collagen as the leading active ingredient category.

Competitive Benchmarking and Company Positioning

Bovine Gelatin Market Analysis By Company

• Gelita holds approximately 12.0% of global revenue through its position as the world's largest gelatin and collagen peptide manufacturer, with production facilities in Germany, Brazil, USA, Australia, and China.
• Rousselot (Darling Ingredients) and PB Leiner compete on production scale, multi-source gelatin production (bovine, porcine, fish), and pharmaceutical-grade capabilities.
• Nitta Gelatin and Weishardt serve specific regional markets with established quality reputations and customer relationships.

The competitive structure is moderately concentrated, with Gelita holding the largest share at 12.0%. Gelita's position is built on its global production network, pharmaceutical-grade quality certifications across multiple pharmacopoeias, and its Peptan collagen peptide brand that has achieved significant consumer and B2B market penetration.

Competition is evolving as collagen peptide supplements create a new revenue stream for gelatin manufacturers. Companies that can convert commodity gelatin production into value-added collagen peptide products capture 3 to 5 times the revenue per kilogram of raw material. Rousselot (Peptan), Gelita (Verisol, Fortigel), and Nitta (Wellnex) are building branded collagen peptide portfolios.

Key Companies in the Bovine Gelatin Market

The bovine gelatin competitive field includes Gelita, Rousselot (Darling Ingredients), PB Leiner, Nitta Gelatin, Weishardt, Sterling Biotech, Trobas Gelatine, Italgel, Ewald-Gelatine, Norland, Tessenderlo, Great Lakes Gelatin, Roxlor, Junca, and Kenney and Ross.

Recent Industry Developments

• Gelita: Verisol skin health collagen expansion (2025)
  • Gelita expanded distribution of its Verisol bioactive collagen peptide product with new clinical data demonstrating skin elasticity and wrinkle reduction benefits in a 12-week randomised controlled trial.
• Rousselot: halal gelatin capacity expansion (2025)
  • Rousselot expanded halal-certified bovine gelatin production capacity at its Brazilian facility, targeting growing demand from pharmaceutical and food manufacturers in halal-conscious markets.
• Nitta Gelatin: pharmaceutical capsule gelatin innovation (2026)
  • Nitta Gelatin developed a new pharmaceutical capsule gelatin grade with improved moisture resistance and enhanced dissolution performance for modified-release capsule applications.
• PB Leiner: collagen peptide clinical programme (2025)
  • PB Leiner published clinical trial results for its bovine collagen peptide product demonstrating joint health benefits in active adults, supporting nutraceutical positioning in the sports nutrition channel.

Leading Companies Shaping the Bovine Gelatin Market

• Global Players

  • Gelita
  • Rousselot (Darling Ingredients)
  • PB Leiner
  • Nitta Gelatin
  • Weishardt

• Regional Players

  • Sterling Biotech
  • Trobas Gelatine
  • Italgel
  • Tessenderlo

• Emerging / Start-up Players

  • Ewald-Gelatine
  • Norland
  • Great Lakes Gelatin
  • Roxlor
  • Junca

Sources and Research References

• Company annual reports from Gelita, Darling Ingredients (Rousselot), and Nitta Gelatin.
• Capsugel/Lonza pharmaceutical capsule production data references.
• CRN dietary supplement market data.
• VDG (Verband Deutscher Gelatine-Hersteller) German gelatin production data.
• Indian Drug Manufacturers Association pharmaceutical production statistics.
• China Gelatin Industry Association consumption data.

All cited sources are first-party company filings, industry associations, or regulatory references. No syndicated market research reports were used.

Key Questions This Report Addresses

• What is the projected market value for bovine gelatin by 2036?
• Which product type holds the largest share?
• What CAGR is forecast from 2026 to 2036?
• How are collagen peptide supplements changing the gelatin value chain?
• Which countries are growing fastest?
• What is the competitive structure?
• How does BSE risk perception affect bovine gelatin acceptance?
• What role does halal certification play in bovine gelatin demand?
• How is pharmaceutical capsule demand driving gelatin growth?

Bovine Gelatin Market Definition

The bovine gelatin market encompasses the production and sale of gelatin derived from bovine collagen through acid or alkaline hydrolysis processes. Products include food-grade, pharmaceutical-grade, industrial-grade, and specialty gelatin in powder, sheet, and liquid forms at varying bloom strengths.

Bovine Gelatin Market Inclusions

• Food-grade bovine gelatin for confectionery, dairy, bakery, and beverage applications.
• Pharmaceutical-grade bovine gelatin for hard and soft capsule shell production.
• Bovine collagen peptides and hydrolysates for nutraceutical supplement applications.
• Industrial-grade bovine gelatin for photography, microencapsulation, and adhesive applications.

Bovine Gelatin Market Exclusions

• Porcine (pig) gelatin products.
• Fish and marine gelatin products.
• Plant-based gelatin alternatives (agar, carrageenan, pectin).
• Bovine collagen used in medical device and wound care applications regulated as medical products.

Bovine Gelatin Market Research Methodology

• Primary research with gelatin manufacturers, pharmaceutical capsule producers, confectionery manufacturers, and nutraceutical companies across 12 countries.
• Revenue modelling based on gelatin production volumes, hide and bone processing data, and manufacturer-reported sales.
• Pricing analysis using B2B gelatin trading data, pharmaceutical procurement records, and food ingredient price lists.
• Competitive share estimation through company annual reports, gelatin industry association data, and production capacity registries.
• Demand validation through pharmaceutical capsule production data, confectionery industry consumption statistics, and collagen supplement market analysis.